U2C Administrative Core
U2C 管理核心
基本信息
- 批准号:10201602
- 负责人:
- 金额:$ 6.28万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-01 至 2022-06-30
- 项目状态:已结题
- 来源:
- 关键词:Big DataBiochemicalCellsChemicalsCollaborationsCommunicationCommunitiesComplementDataDatabasesDedicationsDevelopmentDiseaseDissociationEffectivenessEnvironmental HealthGoalsHealthHumanInfrastructureIonsKnowledgeLaboratoriesLeadLeadershipLifeMaintenanceMovementNational Institute of Environmental Health SciencesPatternPharmacologyResearchResearch PersonnelResolutionRoleSamplingScheduleScienceServicesStructureSupport SystemSystemTestingTimeTrainingUniversitiesWorkXenobiotic MetabolismXenobioticsadductcareer developmentdesignenvironmental chemicalexperienceflexibilityimprovedinnovationlaboratory facilitymeetingsmetabolomicsoutreachprofessorprogramsskillssuccesstooltool developmentusability
项目摘要
Administrative Core Project Summary
The Administrative Core serves critical leadership, organizational and identity roles for the Compound Identity
Discovery Core (CIDC) at Emory University. Dr. Jones will serve as Core Director and maintain overall
organization through regular interactions with MPIs Dr Miller, Dr Morgan and Dr Li. Dr Jones has expertise in
metabolomics and long-term scientific collaborations and academic interactions with other proven scientific
leaders of the Core, Dr Miller and Dr Morgan. The Core is designed to maintain a high level of flexibility for Dr
Morgan's leadership in the Experimental Core to develop arrays of cell systems for targeted xenobiotic
biochemical transformation while at the same time coordinating this with Dr Li's development of computational
systems to support high throughput chemical identification. The Core is further designed to complement
central tool development goals with activities of the Metabolomics Consortium, support service for exposome-
related metabolite identification and metabolomics training and career development. Dr Miller, Director of the
NIEHS-supported HERCULES Human Exposome Research Center at Emory, will be Co-Director for
Exposome Outreach and Exposome Metabolite Identification. Dr Morgan will be Co-Director for Metabolomics
Training and Career Development. Together, these investigators bring a high degree of organization and
management experience to the Emory CIDC. The goals of the Core are to 1) Provide leadership and guidance
for the Emory CIDC. The Core will work to assure that the complementary group of Emory CIDC laboratories
and facilities work efficiently as a team to assure success in development of compound identification tools for
xenobiotic metabolites. 2) Assure progress of the Computational Core and Experimental Core in achieving
their objectives. These cores are distinct but interdependent; the Administrative Core will work to assure that
the Computational Core and the Experimental Core each achieve its goals, thereby helping assure the overall
success in tool development. 3) Develop an infrastructure for servicing needs of the exposome research
community in identification of environmental metabolites associated with disease. The Administrative Core will
work with HERCULES Human Exposome Research Center to develop a structure to support real-life testing of
xenobiotic metabolite identification tools to benefit stakeholders and improve design and usability. 4) Facilitate
communication between the Emory CIDC and the Metabolomics Consortium leadership, other Metabolomics
Consortium components and stakeholders. The Administrative Core will serve as the primary conduit for
interaction with the Metabolomics Consortium and will support additional outreach, training and career
development objectives. The combined expertise and leadership skills of the Administrative Core will assure
that the Emory CIDC achieves its goals to develop powerful new chemical identification tools that are scalable
to identify hundreds of thousands of metabolites of environmental chemicals and other components of the
human exposome.
行政核心项目概要
管理核心为复合身份提供关键的领导、组织和身份角色
埃默里大学的发现核心 (CIDC)。琼斯博士将担任核心董事并维持整体
通过与 MPI 米勒博士、摩根博士和李博士定期互动来组织。琼斯博士拥有以下方面的专业知识:
代谢组学以及与其他经过验证的科学领域的长期科学合作和学术互动
核心领导人米勒博士和摩根博士。核心旨在保持博士的高度灵活性
摩根在实验核心领域的领导地位,致力于开发针对目标异生素的细胞系统阵列
生化转化,同时与李博士的计算发展相协调
系统支持高通量化学鉴定。该核心的进一步设计是为了补充
代谢组学联盟活动的中心工具开发目标,暴露组的支持服务
相关代谢物鉴定和代谢组学培训和职业发展。米勒博士,主任
NIEHS 支持的埃默里大学 HERCULES 人类暴露组研究中心将担任该中心的联合主任
暴露组外展和暴露组代谢物鉴定。摩根博士将担任代谢组学联合主任
培训和职业发展。这些调查人员共同带来了高度的组织和
埃默里 CIDC 的管理经验。核心的目标是 1) 提供领导和指导
埃默里大学 CIDC。核心将努力确保埃默里大学 CIDC 实验室的互补小组
和设施作为一个团队有效地工作,以确保成功开发化合物识别工具
外源代谢物。 2)确保计算核心和实验核心在实现目标方面取得进展
他们的目标。这些核心各不相同但又相互依赖;行政核心将努力确保
计算核心和实验核心各自实现其目标,从而有助于确保整体
工具开发的成功。 3) 开发满足暴露研究服务需求的基础设施
社区识别与疾病相关的环境代谢物。行政核心将
与 HERCULES 人类暴露组研究中心合作开发一种结构来支持现实生活中的测试
外源代谢物识别工具可以使利益相关者受益并改进设计和可用性。 4)促进
埃默里 CIDC 与代谢组学联盟领导层、其他代谢组学之间的沟通
联盟成员和利益相关者。行政核心将作为主要渠道
与代谢组学联盟互动,并将支持额外的外展、培训和职业生涯
发展目标。行政核心的综合专业知识和领导技能将确保
埃默里 CIDC 实现了开发强大的可扩展的新型化学品识别工具的目标
识别环境化学物质和其他成分的数十万种代谢物
人类暴露组。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Dean Paul Jones其他文献
Dean Paul Jones的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Dean Paul Jones', 18)}}的其他基金
Mega-scale Identification tools for xenobiotic metabolism
外源代谢的大规模鉴定工具
- 批准号:
10201601 - 财政年份:2018
- 资助金额:
$ 6.28万 - 项目类别:
Mega-scale Identification tools for xenobiotic metabolism
外源代谢的大规模鉴定工具
- 批准号:
9769022 - 财政年份:2018
- 资助金额:
$ 6.28万 - 项目类别:
Mega-scale Identification tools for xenobiotic metabolism
外源代谢的大规模鉴定工具
- 批准号:
9981744 - 财政年份:2018
- 资助金额:
$ 6.28万 - 项目类别:
High-Resolution Plasma Metabolomic Profiling to Identify Biomarkers for Tuberculosis Disease and Response to Therapy
高分辨率血浆代谢组学分析可识别结核病生物标志物和治疗反应
- 批准号:
9432482 - 财政年份:2017
- 资助金额:
$ 6.28万 - 项目类别:
High-Resolution Plasma Metabolomic Profiling to Identify Biomarkers for Tuberculosis Disease and Response to Therapy
高分辨率血浆代谢组学分析可识别结核病生物标志物和治疗反应
- 批准号:
9300433 - 财政年份:2017
- 资助金额:
$ 6.28万 - 项目类别:
Georgia Comprehensive Metabolomics and Proteomics Unit for MoTrPAC
佐治亚州 MoTrPAC 综合代谢组学和蛋白质组学单位
- 批准号:
9246760 - 财政年份:2016
- 资助金额:
$ 6.28万 - 项目类别:
Metabolomics of subclinical and clinical cardiovascular disease
亚临床和临床心血管疾病的代谢组学
- 批准号:
8463610 - 财政年份:2012
- 资助金额:
$ 6.28万 - 项目类别:
Metabolomics of subclinical and clinical cardiovascular disease
亚临床和临床心血管疾病的代谢组学
- 批准号:
8625332 - 财政年份:2012
- 资助金额:
$ 6.28万 - 项目类别:
Metabolomics of subclinical and clinical cardiovascular disease
亚临床和临床心血管疾病的代谢组学
- 批准号:
8286494 - 财政年份:2012
- 资助金额:
$ 6.28万 - 项目类别:
相似国自然基金
植物细胞内免疫受体的生化功能与信号转导的分子机理研究
- 批准号:
- 批准年份:2022
- 资助金额:54 万元
- 项目类别:面上项目
力信号与生化信号协同调制免疫细胞两个关键界面过程的生物物理研究
- 批准号:
- 批准年份:2022
- 资助金额:55 万元
- 项目类别:面上项目
基于新型衍生化的单细胞代谢组学技术与AI辅助的多维组学整合策略
- 批准号:32150024
- 批准年份:2021
- 资助金额:300 万元
- 项目类别:国际(地区)合作与交流项目
HRAS突变通过诱导PNMT基因表达调控嗜铬细胞瘤/副神经节瘤儿茶酚胺生化表型的机制研究
- 批准号:82170806
- 批准年份:2021
- 资助金额:55 万元
- 项目类别:面上项目
TWEAK/Fn14信号调控毛囊干细胞功能及促进表皮再生化的分子机制
- 批准号:82173445
- 批准年份:2021
- 资助金额:55 万元
- 项目类别:面上项目
相似海外基金
2023 Collagen Gordon Research Conference and Seminar
2023年胶原蛋白戈登研究会议暨研讨会
- 批准号:
10675849 - 财政年份:2023
- 资助金额:
$ 6.28万 - 项目类别:
Disrupting Dogma: Investigating LPS Biosynthesis Inhibition as an Alternative Mechanism of Action of Aminoglycoside Antibiotics
颠覆教条:研究 LPS 生物合成抑制作为氨基糖苷类抗生素的替代作用机制
- 批准号:
10653587 - 财政年份:2023
- 资助金额:
$ 6.28万 - 项目类别:
2023 Barrier Function of Mammalian Skin Gordon Research Conferences and Gordon Research Seminar
2023年哺乳动物皮肤屏障功能戈登研究会议及戈登研究研讨会
- 批准号:
10683587 - 财政年份:2023
- 资助金额:
$ 6.28万 - 项目类别:
2023 Barrier Function of Mammalian Skin Gordon Research Conferences and Gordon Research Seminar
2023年哺乳动物皮肤屏障功能戈登研究会议及戈登研究研讨会
- 批准号:
10683587 - 财政年份:2023
- 资助金额:
$ 6.28万 - 项目类别:
Chemical Fingerprints of Cognitive Impairment-related alpha-Synuclein Strains using 3D Small Molecule Microarray and Related Therapeutic Application
使用 3D 小分子微阵列的认知障碍相关 α-突触核蛋白菌株的化学指纹及相关治疗应用
- 批准号:
10360139 - 财政年份:2022
- 资助金额:
$ 6.28万 - 项目类别: